Skip to main content
. 2020 Nov 10;23(1):43. doi: 10.3892/mmr.2020.11681

Figure 6.

Figure 6.

Association between disease activity and miRNA-155-5p/miRNA-125b-5p in activated CD4+ T cells from patients with pSS. (A) Proliferation of CD4+ T cells, (B) number of CD4+ IFN-γ+ cells, (C) supernatant IFN-γ secretion and expression levels of (D) miRNA-155-5p and (E) miRNA-125b-5p in CD4+ T cells were in patients with inactive (ESSDAI ≤2; n=6) and active disease (ESSDAI >2; n=6) from pSS activation and MSC treatment groups. Data are presented as the mean ± SEM. *P<0.05. miRNA, microRNA; pSS, primary Sjögren syndrome; ESSDAI, EULAR Sjögren's syndrome disease activity index; MSC, mesenchymal stem cell; ns, not significant.